IKBKB could be activated by α-KG produced by GDH1 and then upregulate GLUT1 to promote glucose uptake and tumor cell survival, thus accelerating the occurrence of glioma (Wang et al., 2019). Here, SLC2A1 is linked to central nervous system cancer.